Sign In
Buy RGLS
$8.16
+0 (+0%)
At Close: Sep 24, 2025
Regulus Therapeutics Announces Achievement of Interim Enrollment Milestone Under Collaboration with Sanofi
08:07am, Monday, 02'nd Nov 2020
LA JOLLA, Calif., Nov. 2, 2020 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNA
